Kirkpatrick Lynn

Chief Scientific Officer at Cascadian Therapeutics, Inc. · on record since Nov 21, 2007
Director at Ensysce Biosciences, Inc. · on record since Jul 2, 2021
Chief Executive Officer at Ensysce Biosciences, Inc. · on record since Jul 2, 2021

Insider trading activity of Kirkpatrick Lynn

Transactions on record: 17; since Dec 12, 2007

Open-market buys: 2; $48.6K

Open-market sells: 0

Companies traded: 2; last filing May 27, 2022

Figures computed from official regulatory filings — .

Companies where Kirkpatrick Lynn has traded

Ensysce Biosciences, Inc.12 tx · $48.6K · May 27, 2022
Cascadian Therapeutics, Inc.5 tx · Jun 5, 2008

Track record of Kirkpatrick Lynn

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Kirkpatrick Lynn

Co-insiders of Kirkpatrick Lynn

ACM Capital Partners, LLCCascadian Therapeutics, Inc.
Ayer Capital Management, LPCascadian Therapeutics, Inc.
Ayer Capital Partners, LLCCascadian Therapeutics, Inc.
Benton AndrewEnsysce Biosciences, Inc.
BIOTECHNOLOGY VALUE FUND II LPCascadian Therapeutics, Inc.
BIOTECHNOLOGY VALUE FUND L PCascadian Therapeutics, Inc.
Biotechnology Value Trading Fund OS LPCascadian Therapeutics, Inc.
Birkett Kevin GeoffreyEnsysce Biosciences, Inc.
Blair S. RobertCascadian Therapeutics, Inc.
Burley StephenCascadian Therapeutics, Inc.
BVF INC/ILCascadian Therapeutics, Inc.
BVF PARTNERS L P/ILCascadian Therapeutics, Inc.
BVF Partners OS Ltd.Cascadian Therapeutics, Inc.
Carrera EricEnsysce Biosciences, Inc.
Chang William HEnsysce Biosciences, Inc.
Christianson GaryCascadian Therapeutics, Inc.
EASTLAND JULIA MARIECascadian Therapeutics, Inc.
Falcone Marc J.Ensysce Biosciences, Inc.
Fyfe Gwen A.Cascadian Therapeutics, Inc.
GOWER BOB GEnsysce Biosciences, Inc.
HAUSMAN DIANACascadian Therapeutics, Inc.
HENNEY CHRISTOPHER SCascadian Therapeutics, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Ensysce Biosciences, Inc.Listing on record	May 27, 2022	AwardD (derivative)	200,000	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	May 27, 2022	Buy	27,000	0.53 USD	$14.3K	conv 47	SEC
Ensysce Biosciences, Inc.Listing on record	May 27, 2022	Buy	70,000	0.49 USD	$34.3K	conv 68First in 12mo	SEC
Ensysce Biosciences, Inc.Listing on record	Feb 24, 2022	AwardD (derivative)	200,000	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	9,994	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	460,950	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	658,500	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	99,950	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	6,585	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	Award	284,851	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	263,400	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	817,560	—	n/a (No price was disclosed in the filing)		SEC
Cascadian Therapeutics, Inc.Listing unverified	Jun 5, 2008	AwardD (derivative)	10,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cascadian Therapeutics, Inc.Listing unverified	Dec 12, 2007	Other	813,633	—	n/a (No price was disclosed in the filing)		SEC
Cascadian Therapeutics, Inc.Listing unverified	Dec 12, 2007	OtherD (derivative)	12,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cascadian Therapeutics, Inc.Listing unverified	Dec 12, 2007	OtherD (derivative)	8,333	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cascadian Therapeutics, Inc.Listing unverified	Dec 12, 2007	Other	800,239	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Ensysce Biosciences, Inc.Listing on record	May 27, 2022	AwardD (derivative)	200,000	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	May 27, 2022	Buy	27,000	0.53 USD	$14.3K	conv 47	SEC
Ensysce Biosciences, Inc.Listing on record	May 27, 2022	Buy	70,000	0.49 USD	$34.3K	conv 68First in 12mo	SEC
Ensysce Biosciences, Inc.Listing on record	Feb 24, 2022	AwardD (derivative)	200,000	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	9,994	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	460,950	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	658,500	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	99,950	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	6,585	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	Award	284,851	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	263,400	—	n/a (No price was disclosed in the filing)		SEC
Ensysce Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	817,560	—	n/a (No price was disclosed in the filing)		SEC
Cascadian Therapeutics, Inc.Listing unverified	Jun 5, 2008	AwardD (derivative)	10,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cascadian Therapeutics, Inc.Listing unverified	Dec 12, 2007	Other	813,633	—	n/a (No price was disclosed in the filing)		SEC
Cascadian Therapeutics, Inc.Listing unverified	Dec 12, 2007	OtherD (derivative)	12,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cascadian Therapeutics, Inc.Listing unverified	Dec 12, 2007	OtherD (derivative)	8,333	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cascadian Therapeutics, Inc.Listing unverified	Dec 12, 2007	Other	800,239	—	n/a (No price was disclosed in the filing)		SEC